Medicine

New Imaging Drug for Ovarian Cancer

New Imaging Drug for Ovarian Cancer

In November of 2021, the Food and Drug Administration (FDA) approved Cytalux. Cytalux is a new imaging drug intended to assist surgeons with the identification of ovarian cancer lesions1. This new drug was designed to assist in locating additional ovarian cancer tissues that can be…

Pop Healthcare

Pop Healthcare

‌  For a long time, healthcare was in the hands of doctors. People listened only to their doctor’s advice on how...

Hospitals of the Future

Hospitals of the Future

‌  Movies, books, and television shows have imagined what the world will look like in the future. From flying cars to...

Why Perform a Gap Analysis?

Why Perform a Gap Analysis?

‌  As new technologies continuously push the limits of medical devices and drugs, regulations and governing...

FDA Approves Comirnaty

FDA Approves Comirnaty

‌  The day has come where the U.S. Food and Drug Administration finally approves the first COVID-19 vaccination for...

Ready to learn more about working with us?

Pin It on Pinterest